LyfeMD

What LyfeMD does

LyfeMD Inc. is a Calgary, Canada-based virtual clinic founded in 2020 that delivers subscription-based, personalized nutrition, mental wellness, and movement coaching to patients managing inflammatory bowel disease (Crohn's disease and ulcerative colitis) and inflammatory arthritis, with an IBS-focused extension marketed as Flare Fighter. The platform operates as a direct-to-consumer telehealth service: patients self-enroll via the website through a four-step flow (book a call, meet a health coach, find a practitioner match, and receive ongoing virtual support) delivered through a web portal and dedicated mobile app authenticated via Microsoft Azure AD B2C. Optional microbiome testing is incorporated into personalized nutrition recommendations, and the clinical model is explicitly positioned as complementary to — not a replacement for — pharmacologic treatment.

The company is led by three clinician-researcher co-founders — Dr. Lorian Taylor (PhD, RD), Dr. Maitreyi Raman (MD, FRCPC), and Dr. Puneeta Tandon (MD, FRCPC) — described as world-leading experts in nutrition and behavior change for chronic inflammatory conditions. Revenue is generated through recurring patient subscriptions for personalized care plans, health coaching, and patient education. Patient out-of-pocket cost is frequently offset through coverage programs run by three pharmaceutical partners (Celltrion, Organon, Pfizer) and through insurance. LyfeMD has secured reputational endorsements from three Canadian organizations in its clinical space: the Canadian Digestive Health Foundation (CDHF), the Canadian Association of Gastroenterology (CAG), and Crohn's & Colitis Canada.

Operationally, LyfeMD runs a multi-channel content engine that includes an IBD-focused blog, the 'LyfeMD Living' podcast hosted on Buzzsprout, and active social media accounts on Facebook, LinkedIn, Instagram, and YouTube. Distribution combines DTC self-serve enrollment, a healthcare-referrer channel for physicians and specialists, and payer-mediated access through the three pharma coverage partnerships. Headcount is reported at 11–50 employees, no institutional equity investors or external parent company are disclosed, and documented capital to date consists of two Canadian grant/seed events in 2022 (Innovate Calgary, UCeed) and 2023 (Business Development Bank of Canada, Startupfest). LyfeMD operates as a privately held, founder-led specialty virtual care provider serving the Canadian market.

Name

LyfeMD

Legal name

LyfeMD Inc.

Website

https://lyfemd.ca

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

LyfeMD is a Calgary-based virtual clinic offering subscription-based personalized nutrition, mental wellness, and movement coaching for patients with IBD, inflammatory arthritis, and IBS, with care costs partially offset through partnerships with Celltrion, Organon, and Pfizer.

Ownership category

akta.pro rank

Product category

Digital Health Virtual Care

NAICS

Offices of Physicians (6211), Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industry

General Gastroenterology (HLAKAEAA)

Keywords

• Virtual clinic services
• Digital health coaching
• Chronic disease management
• Nutrition guidance platform
• IBD care program

Headquarters

HQ city

Calgary

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Virtual Clinic Services: LyfeMD provides virtual healthcare coaching and support services for patients with IBD and inflammatory arthritis. Revenue is generated through patient subscriptions for personalized nutrition guidance, mental wellness support, health coaching, and patient education services.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

LyfeMD operates a doctor-recommended virtual clinic that delivers personalized, evidence-based care plans covering nutrition guidance (with optional microbiome testing), mental wellness support, health coaching, and patient education for individuals managing inflammatory bowel disease (Crohn's disease, ulcerative colitis) and inflammatory arthritis. Patients self-enroll via the website or app, are matched with a coach and practitioner, and receive ongoing virtual check-ins that complement their existing medical treatment.

Product overview

LyfeMD is a single unified virtual clinic platform providing personalized, evidence-based care for chronic inflammatory conditions. The core offering consists of the LyfeMD Virtual Clinic (nutrition guidance with optional microbiome testing, mental wellness support, health coaching, and patient education) along with the LyfeMD for IBS sub-product (Flare Fighter). All services are tied together through personalized care plans, ongoing health coaching, and regular virtual check-ins.

Differentiator

Problem solved

Functional benefit

Brands

• Flare Fighter: A product line specifically for IBS patients, accessible at flarefighter.com/ibs/

Products and services

• LyfeMD Virtual Clinic A doctor-recommended virtual clinic providing practical guidance on nutrition, mental wellness, and movement for patients managing IBD (Crohn's disease and ulcerative colitis) and inflammatory arthritis. Creates personalized care plans tailored to individual conditions, goals, and daily life. Includes optional microbiome testing, health coaching with regular check-ins, and patient education resources.
• LyfeMD for IBS (Flare Fighter) Specialized program targeting irritable bowel syndrome, part of the LyfeMD ecosystem branded as Flare Fighter, providing tailored guidance for IBS patients.

Quantifiable outcome

• Fewer flares and improved energy (patient-reported)
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Canadian Digestive Health Foundation (CDHF)coreStrategic or Co-development PartnerCDHF is listed under 'SUPPORTED BY' on LyfeMD's website, indicating a strategic endorsement or partnership. CDHF is a major Canadian nonprofit focused on digestive health education and awareness.
• Canadian Association of Gastroenterology (CAG)coreStrategic or Co-development PartnerCAG is listed under 'SUPPORTED BY' on LyfeMD's website. CAG is the professional body for gastroenterologists in Canada, suggesting clinical endorsement or collaborative alignment.
• Crohn's & Colitis CanadacoreStrategic or Co-development PartnerCrohn's & Colitis Canada is listed under 'SUPPORTED BY' on LyfeMD's website. This is Canada's main nonprofit dedicated to Crohn's disease and ulcerative colitis research and support.
• OrganoncoreGTM or Marketing PartnerOrganon is listed as a partner and their care coverage program helps patients access LyfeMD services. Organon is a global healthcare company focused on women's health.
• PfizercoreGTM or Marketing PartnerPfizer is listed as a partner and their care coverage program helps patients access LyfeMD services. Pfizer is a major pharmaceutical company.
• CelltrionminorGTM or Marketing PartnerCelltrion is mentioned as providing coverage for LyfeMD care services. Celltrion is a biopharmaceutical company developing biosimilar drugs.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Oshi Health: Virtual-first gastroenterology clinic providing telehealth visits, nutrition, and behavioral health for IBS, IBD, and other GI conditions. Most directly comparable to LyfeMD in modality (virtual GI clinic) and condition focus, though operating at larger US scale.
• Ayble Health: Digital health platform delivering personalized nutrition, gut-brain therapy and care pathways for IBD and IBS patients. Closely comparable to LyfeMD's condition-specific, dietitian-and-coaching-led approach.
• Trellus Health: Digital therapeutic platform specifically built around IBD self-management, combining psychology, nutrition, and remote coaching. Directly overlaps with LyfeMD's IBD virtual-clinic offering and condition-specific coaching model.
• Vivante Health: GI-focused digital health company offering virtual care, nutrition and symptom tracking for digestive conditions including IBD and IBS. Comparable virtual GI clinic structure with employer and payor channels.
• Bold Health (Mahana Therapeutics / Cara Care): Digital therapeutics for IBS and related GI conditions, with prescription and self-pay pathways. Comparable condition-specific digital therapeutic model targeting the same IBS/IBD patient base as LyfeMD.

Broad incumbents

• GI OnDEMAND: Telehealth platform from the American College of Gastroenterology connecting patients to gastroenterologists and dietitians. Overlaps with LyfeMD's GI virtual care and dietitian-led model, but broader in scope and US-based.
• Headspace Health (Ginger / Headspace): Large-scale mental wellness platform; intersects with LyfeMD's mental wellness component (stress, sleep) and shows how a coaching-led mental wellness layer could scale or be competed against by incumbents.

Emerging players

• Mymee: Digital care program for autoimmune and inflammatory conditions using diet, lifestyle, and remote coaching. Comparable coaching-led, condition-specific chronic care model adjacent to LyfeMD's IBD and arthritis focus.
• Wellory: Anti-diet nutrition coaching platform delivered via app. Comparable consumer-facing coaching and nutrition guidance model, though broader than LyfeMD and not condition-specific.

Regional players

• Salaso Health: Ireland-based digital therapeutics and virtual care platform for chronic disease self-management. Comparable chronic-condition coaching and remote-monitoring model, with comparable English-language, single-country footprint and clinical-credibility-led approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@BethehealthiesthappiestYOU
• Facebookfacebook.com/lyfemd
• LinkedInlinkedin.com/company/lyfemd
• Instagraminstagram.com/lyfemd_official
• Xx.com/lyfemd

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LyfeMD